— Know what they know.
Not Investment Advice

CXM NYSE

Sprinklr, Inc.
1W: +6.9% 1M: +0.8% 3M: -5.5% YTD: -27.9% 1Y: -36.1% 3Y: -54.7%
$5.27
-0.01 (-0.19%)
 
Weekly Expected Move ±7.2%
$4 $5 $5 $5 $6
NYSE · Technology · Software - Application · Alpha Radar Neutral · Power 50 · $1.3B mcap · 185M float · 2.14% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.0 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 38.6%  ·  5Y Avg: -12.5%
Cost Advantage
43
Intangibles
14
Switching Cost
34
Network Effect
49
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CXM has No discernible competitive edge (34.0/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 38.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$6
Low
$6
Avg Target
$6
High
Based on 1 analyst since Mar 11, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 9Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$6.25
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-17 D.A. Davidson Clark Wright $10 $6 -3 +13.1% $5.53
2025-12-03 Cantor Fitzgerald Matthew VanVliet $10 $8 -2 +3.0% $7.76
2025-09-03 Barclays Raimo Lenschow $7 $8 +1 +3.4% $7.74
2024-12-05 D.A. Davidson Clark Wright $8 $10 +2 +12.9% $8.41
2024-10-07 Barclays Raimo Lenschow $11 $7 -4 -6.2% $7.46
2024-09-05 Rosenblatt Securities Catherine Trebnick $11 $10 -0 +31.7% $7.97
2024-09-05 KeyBanc Jackson Ader $16 $12 -4 +39.7% $8.59
2024-09-05 D.A. Davidson Clark Wright $9 $8 -1 -6.9% $8.59
2024-09-03 Rosenblatt Securities Catharine Trebnick $14 $11 -3 +22.6% $8.97
2024-06-21 Wells Fargo Michael Turrin $10 $9 -1 +5.5% $8.53
2024-06-06 Stifel Nicolaus Parker Lane $15 $9 -6 -0.1% $9.01
2024-06-06 Rosenblatt Securities Catherine Trebnick $18 $14 -4 +29.2% $10.84
2024-06-06 Wells Fargo Michael Turrin $9 $10 +1 -7.7% $10.84
2024-06-06 D.A. Davidson Gil Luria Initiated $9 -17.0% $10.84
2024-06-06 Barclays Raimo Lenschow $10 $11 +1 +1.5% $10.84
2024-06-05 Cantor Fitzgerald Brett Knoblauch Initiated $10 -7.7% $10.84
2024-06-05 KeyBanc Jackson Ader $19 $16 -3 +77.3% $9.03
2024-03-28 Rosenblatt Securities Catherine Trebnick Initiated $18 +38.4% $13.01
2024-03-20 KeyBanc Jackson Ader Initiated $19 +44.8% $13.12
2023-01-10 Barclays $15 $10 -5 +25.6% $7.96
2022-12-07 Morgan Stanley $14 $10 -4 +20.8% $8.28
2022-12-07 Wells Fargo Initiated $9 +11.1% $8.10
2022-12-07 JMP Securities Initiated $16 +93.9% $8.25
2022-12-07 Oppenheimer Initiated $10 +21.2% $8.25
2022-09-15 Citigroup $12 $13 +1 +23.5% $10.53
2022-09-09 Morgan Stanley $12 $14 +2 +15.2% $12.15
2022-06-28 Morgan Stanley Elizabeth Porter Initiated $12 +5.4% $11.39
2022-06-28 Stifel Nicolaus Parker Lane $18 $15 -3 +31.7% $11.39
2022-06-28 Barclays Raimo Lenschow $14 $15 +1 +31.7% $11.39
2022-06-16 Citigroup Initiated $12 +16.1% $10.34
2022-06-15 J.P. Morgan Initiated $15 +49.4% $10.04
2022-05-22 Barclays Raimo Lenschow Initiated $14 +23.8% $11.31
2022-03-27 Stifel Nicolaus Parker Lane $26 $18 -8 +54.8% $11.63
2022-01-22 Stifel Nicolaus Parker Lane Initiated $26 +142.1% $10.74

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
5
ROE
3
ROA
3
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CXM receives an overall rating of B+. Strongest factors: DCF (5/5). Areas of concern: P/E (1/5).
Rating Change History
DateFromTo
2026-05-04 B B+
2026-04-01 B+ B
2026-03-24 B B+
2026-03-11 A B
2026-02-24 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

65 Grade A
Profitability
54
Balance Sheet
90
Earnings Quality
69
Growth
62
Value
45
Momentum
84
Safety
65
Cash Flow
80
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CXM scores highest in Balance Sheet (90/100) and lowest in Value (45/100). An overall grade of A places CXM among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.93
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.16
Unlikely Manipulator
Ohlson O-Score
-8.15
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 79.5/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.11x
Accruals: -1.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CXM scores 2.93, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CXM scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CXM's score of -2.16 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CXM's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CXM receives an estimated rating of A+ (score: 79.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CXM's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
56.96x
PEG
-0.70x
P/S
1.54x
P/B
2.20x
P/FCF
19.16x
P/OCF
17.90x
EV/EBITDA
36.46x
EV/Revenue
2.37x
EV/EBIT
40.59x
EV/FCF
15.66x
Earnings Yield
5.04%
FCF Yield
5.22%
Shareholder Yield
5.73%
Graham Number
$4.86
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 57.0x earnings, CXM is priced for high growth expectations. An earnings yield of 5.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $4.86 per share, 8% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.084
NI / EBT
×
Interest Burden
1.202
EBT / EBIT
×
EBIT Margin
0.058
EBIT / Rev
×
Asset Turnover
0.682
Rev / Assets
×
Equity Multiplier
1.864
Assets / Equity
=
ROE
18.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CXM's ROE of 18.6% is driven by Asset Turnover (0.682), indicating efficient use of assets to generate revenue. A tax burden ratio of 2.08 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
144.31%
Fair P/E
297.13x
Intrinsic Value
$135.04
Price/Value
0.07x
Margin of Safety
93.33%
Premium
-93.33%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CXM's realized 144.3% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $135.04, CXM appears undervalued with a 93% margin of safety. The adjusted fair P/E of 297.1x compares to the current market P/E of 57.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1235 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.28
Median 1Y
$3.60
5th Pctile
$1.54
95th Pctile
$8.43
Ann. Volatility
52.7%
Analyst Target
$6.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joy Corso Administrative
rative Officer
$475,000 $10,602,293 $11,705,643
Scott Millard Revenue
Chief Revenue Officer
$65,160 $7,982,653 $8,118,967
Karthik Suri Product
roduct and Corporate Strategy Officer
$134,615 $7,114,349 $7,911,525
Anthony Coletta Financial
ancial Officer
$146,551 $5,135,597 $5,476,763
Sanjay Macwan Information
mation Officer
$312,196 $4,455,200 $5,054,146
Manish Sarin Financial
ief Financial Officer
$307,692 $4,083,500 $4,845,048
Rory Read
President and Chief Executive Officer
$675,000 $— $1,664,700

CEO Pay Ratio

13:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,664,700
Avg Employee Cost (SGA/emp): $130,374
Employees: 3,258

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,258
-9.2% YoY
Revenue / Employee
$263,106
Rev: $857,200,000
Profit / Employee
$7,030
NI: $22,905,000
SGA / Employee
$130,374
Avg labor cost proxy
R&D / Employee
$29,466
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -18.2% -34.2% -19.3% -24.2% -33.0% -26.3% -10.5% -5.2% 1.3% 5.6% 8.4% 9.6% 8.2% 7.2% 18.8% 16.9% 18.6% 18.61%
ROA -5.7% -10.7% -10.8% -13.6% -15.3% -12.2% -5.7% -2.8% 0.7% 3.0% 4.6% 5.3% 4.5% 3.9% 10.1% 9.1% 10.0% 9.98%
ROIC 1.2% 2.3% 4.4% 5.5% 5.1% 4.1% 3.2% 2.0% 19.5% -93.7% 57.0% 69.6% 56.7% 46.7% 34.0% 25.3% 38.6% 38.63%
ROCE -10.4% -19.1% -14.2% -18.5% -17.1% -13.3% -9.0% -5.5% 0.5% 3.7% 5.8% 7.0% 5.2% 4.5% 3.6% 4.9% 7.2% 7.20%
Gross Margin 68.5% 69.5% 70.7% 71.2% 72.0% 74.2% 76.2% 75.8% 75.6% 75.1% 75.5% 73.9% 72.5% 71.2% 71.0% 69.5% 68.2% 68.20%
Operating Margin -24.7% -20.7% -26.4% -16.0% -14.4% -2.9% -1.1% -1.8% 3.1% 7.1% 9.5% 2.9% -0.0% 3.9% 5.2% -0.9% 7.7% 7.67%
Net Margin -28.0% -23.0% -27.2% -17.4% -15.9% -3.7% -0.4% 1.6% 5.9% 9.1% 10.9% 5.4% 0.9% 5.2% 48.7% -0.8% 5.9% 5.95%
EBITDA Margin -23.3% -17.8% -16.5% -14.2% -12.4% -0.9% 0.9% 0.2% 9.3% 9.2% 11.7% 5.2% 2.3% 4.6% 5.9% 7.7% 7.8% 7.76%
FCF Margin -8.9% -6.0% -8.6% -7.3% -4.7% -4.1% 1.7% 4.7% 5.6% 7.8% 7.0% 9.7% 10.5% 8.9% 7.4% 12.8% 15.2% 15.15%
OCF Margin -5.4% -3.1% -5.9% -4.8% -2.3% -1.8% 4.3% 7.4% 8.4% 10.8% 9.8% 12.5% 13.1% 11.4% 9.7% 14.8% 16.2% 16.22%
ROE 3Y Avg snapshot only 9.44%
ROE 5Y Avg snapshot only -2.45%
ROA 3Y Avg snapshot only 4.98%
ROIC 3Y Avg snapshot only 32.29%
ROIC Economic snapshot only 10.63%
Cash ROA snapshot only 11.24%
Cash ROIC snapshot only 75.08%
CROIC snapshot only 70.13%
NOPAT Margin snapshot only 8.34%
Pretax Margin snapshot only 7.03%
R&D / Revenue snapshot only 11.19%
SGA / Revenue snapshot only 52.91%
SBC / Revenue snapshot only 8.91%
Valuation
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -147.07 -78.83 -28.97 -28.12 -25.44 -26.17 -46.74 -121.72 588.93 124.54 70.05 56.06 52.84 44.16 19.56 18.04 19.83 56.961
P/S Ratio 41.20 20.04 7.55 6.66 5.26 4.09 4.21 5.20 5.91 5.24 4.92 4.40 3.45 2.47 2.99 2.45 2.90 1.542
P/B Ratio 26.76 26.95 5.58 6.80 5.69 4.67 4.74 6.13 7.25 6.71 5.30 4.88 3.93 2.86 3.89 3.22 3.89 2.201
P/FCF -461.08 -335.49 -87.97 -90.93 -110.67 -99.83 255.13 111.06 106.04 66.82 70.41 45.44 33.05 27.85 40.20 19.09 19.16 19.160
P/OCF 97.72 69.91 70.14 48.35 50.38 35.09 26.37 21.74 30.65 16.49 17.90 17.898
EV/EBITDA -169.67 -94.08 -32.30 -31.89 -28.49 -29.71 -52.16 -153.87 201.50 87.97 52.45 40.44 37.48 28.22 54.13 37.08 36.46 36.463
EV/Revenue 39.50 19.22 6.15 5.65 4.30 3.19 3.31 4.34 5.08 4.44 4.06 3.56 2.64 1.67 2.44 1.91 2.37 2.373
EV/EBIT -158.97 -87.06 -31.11 -30.18 -26.47 -26.57 -39.89 -89.58 1100.08 149.43 72.15 53.73 54.84 41.20 81.76 47.18 40.59 40.586
EV/FCF -442.04 -321.74 -71.70 -77.12 -90.59 -77.75 200.11 92.51 91.09 56.63 58.10 36.82 25.27 18.85 32.85 14.88 15.66 15.664
Earnings Yield -0.7% -1.3% -3.5% -3.6% -3.9% -3.8% -2.1% -0.8% 0.2% 0.8% 1.4% 1.8% 1.9% 2.3% 5.1% 5.5% 5.0% 5.04%
FCF Yield -0.2% -0.3% -1.1% -1.1% -0.9% -1.0% 0.4% 0.9% 0.9% 1.5% 1.4% 2.2% 3.0% 3.6% 2.5% 5.2% 5.2% 5.22%
Price/Tangible Book snapshot only 4.239
EV/OCF snapshot only 14.632
EV/Gross Profit snapshot only 3.393
Acquirers Multiple snapshot only 59.269
Shareholder Yield snapshot only 5.73%
Graham Number snapshot only $4.86
Leverage & Solvency
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.63 1.63 2.07 2.07 2.07 2.07 1.88 1.88 1.88 1.88 1.97 1.97 1.97 1.97 1.65 1.65 1.65 1.650
Quick Ratio 1.43 1.43 2.07 2.07 2.07 2.07 1.88 1.88 1.88 1.88 1.97 1.97 1.97 1.97 1.65 1.65 1.65 1.650
Debt/Equity 0.43 0.43 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.05 0.05 0.05 0.05 0.08 0.08 0.08 0.080
Net Debt/Equity -1.10 -1.10 -1.03 -1.03 -1.03 -1.03 -1.02 -1.02 -1.02 -1.02 -0.93 -0.93 -0.93 -0.93 -0.71 -0.71 -0.71 -0.710
Debt/Assets 0.13 0.13 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.041
Debt/EBITDA -2.85 -1.57 -0.00 -0.00 -0.00 -0.00 -0.43 -0.92 0.99 0.47 0.59 0.50 0.61 0.71 1.36 1.17 0.91 0.912
Net Debt/EBITDA 7.31 4.02 7.33 5.71 6.31 8.44 14.34 30.84 -33.07 -15.82 -11.11 -9.46 -11.54 -13.48 -12.11 -10.48 -8.14 -8.138
Interest Coverage -28.76 -37.57 -34.59 -26.91 8.65 10.52 7.83 6.72
Equity Multiplier 3.21 3.21 1.78 1.78 1.78 1.78 1.87 1.87 1.87 1.87 1.80 1.80 1.80 1.80 1.93 1.93 1.93 1.935
Cash Ratio snapshot only 0.934
Cash to Debt snapshot only 9.926
FCF to Debt snapshot only 2.553
Defensive Interval snapshot only 523.9 days
Efficiency & Turnover
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.20 0.42 0.41 0.57 0.74 0.78 0.64 0.66 0.69 0.72 0.65 0.67 0.69 0.70 0.66 0.67 0.68 0.682
Inventory Turnover 0.60 1.22 5.22 5.28
Receivables Turnover 1.02 2.11 2.33 3.22 3.99 4.20 3.35 3.51 3.66 3.82 3.07 3.16 3.24 3.30 2.85 2.88 2.93 2.934
Payables Turnover 2.20 4.48 7.33 9.97 9.91 10.03 7.13 7.14 7.20 7.46 5.54 5.82 6.16 6.51 7.16 7.53 7.95 7.953
DSO 358 173 157 113 92 87 109 104 100 96 119 115 113 110 128 127 124 124.4 days
DIO 608 298 0 0 70 69 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 166 81 50 37 37 36 51 51 51 49 66 63 59 56 51 48 46 45.9 days
Cash Conversion Cycle 799 390 107 77 125 119 58 53 49 47 53 53 53 54 77 78 79 78.5 days
Fixed Asset Turnover snapshot only 10.769
Cash Velocity snapshot only 1.698
Capital Intensity snapshot only 1.443
Growth (YoY)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3.7% 1.4% 62.1% 22.8% 20.8% 19.5% 18.5% 16.8% 14.7% 12.0% 8.7% 6.8% 6.1% 6.08%
Net Income -2.5% -47.2% 43.9% 77.8% 1.1% 1.3% 1.9% 3.1% 6.5% 48.9% 1.4% 84.7% 1.4% 1.38%
EPS -2.4% -44.4% 45.2% 79.8% 1.1% 1.3% 1.8% 3.1% 6.8% 54.2% 1.6% 1.0% 1.4% 1.44%
FCF -1.5% -64.3% 1.3% 1.8% 2.4% 3.3% 4.0% 1.4% 1.2% 26.7% 15.7% 41.5% 53.8% 53.76%
EBITDA -2.1% -25.7% 46.1% 80.5% 1.2% 1.6% 2.4% 4.7% 2.2% 31.4% -36.6% -37.6% -2.0% -2.03%
Op. Income -2.6% -53.3% 44.0% 72.7% 96.1% 1.2% 1.7% 2.4% 10.0% 1.3% -29.2% -61.4% -11.6% -11.58%
OCF Growth snapshot only 31.33%
Asset Growth snapshot only -3.18%
Equity Growth snapshot only -9.95%
Debt Growth snapshot only 46.30%
Shares Change snapshot only -2.76%
Growth (CAGR)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 86.8% 47.5% 27.8% 15.3% 13.7% 13.70%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 91.8% 50.4% 29.3% 15.8% 13.2% 13.18%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 27.8% 27.8% 8.8% 8.8% 8.8% 8.78%
Assets 5Y
Equity 3Y 54.9% 54.9% 5.9% 5.9% 5.9% 5.87%
Book Value 3Y 51.2% 53.6% 4.4% 5.9% 5.1% 5.11%
Dividend 3Y
Growth Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.90 0.92 0.96 1.00 0.87 0.89 0.92 0.97 0.97 0.969
Earnings Stability 0.10 0.53 0.94 1.00 0.47 0.72 0.98 0.98 0.71 0.714
Margin Stability 0.95 0.95 0.96 0.96 0.96 0.96 0.97 0.97 0.96 0.964
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.61 0.19 0.40 0.18 0.185
ROE Trend 0.22 0.31 0.22 0.23 0.18 0.13 0.21 0.16 0.15 0.153
Gross Margin Trend 0.06 0.05 0.04 0.03 0.01 -0.01 -0.02 -0.04 -0.05 -0.049
FCF Margin Trend 0.12 0.13 0.10 0.11 0.10 0.07 0.03 0.06 0.07 0.071
Sustainable Growth Rate 1.3% 5.6% 8.4% 9.6% 8.2% 7.2% 18.8% 16.9% 18.6% 18.61%
Internal Growth Rate 0.7% 3.1% 4.8% 5.6% 4.7% 4.1% 11.2% 10.0% 11.1% 11.09%
Cash Flow Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.19 0.12 0.23 0.20 0.11 0.11 -0.48 -1.74 8.40 2.58 1.39 1.60 2.00 2.03 0.64 1.09 1.11 1.108
FCF/OCF 1.64 1.95 1.45 1.52 2.03 2.32 0.38 0.63 0.66 0.72 0.72 0.77 0.80 0.78 0.76 0.86 0.93 0.934
FCF/Net Income snapshot only 1.035
OCF/EBITDA snapshot only 2.492
CapEx/Revenue 3.5% 2.9% 2.7% 2.5% 2.4% 2.3% 2.7% 2.8% 2.9% 3.0% 2.8% 2.9% 2.6% 2.5% 2.3% 2.0% 1.1% 1.07%
CapEx/Depreciation snapshot only 1.616
Accruals Ratio -0.05 -0.09 -0.08 -0.11 -0.14 -0.11 -0.08 -0.08 -0.05 -0.05 -0.02 -0.03 -0.05 -0.04 0.04 -0.01 -0.01 -0.011
Sloan Accruals snapshot only -0.134
Cash Flow Adequacy snapshot only 15.183
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.5% 34.6% 51.9% 2.1% 5.9% 52.8% 2.8% 94.5% 1.1% 1.14%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.3% 0.3% 0.3% 0.7% 3.8% 11.2% 1.2% 0.1% 5.2% 5.7% 5.73%
Net Buyback Yield 0.0% -0.0% -0.0% -0.2% -0.6% -0.9% -0.9% -0.9% -0.8% -1.1% -0.3% 3.1% 10.8% 1.2% 0.1% 5.1% 5.1% 5.07%
Total Shareholder Return 0.0% -0.0% -0.0% -0.2% -0.6% -0.9% -0.9% -0.9% -0.8% -1.1% -0.3% 3.1% 10.8% 1.2% 0.1% 5.1% 5.1% 5.07%
DuPont Factors
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.08 1.07 1.05 1.06 1.07 1.09 1.17 1.20 0.59 0.86 0.85 0.82 0.77 0.74 2.52 2.72 2.08 2.084
Interest Burden (EBT/EBIT) 1.04 1.07 1.25 1.19 1.19 1.19 0.93 0.74 3.67 1.65 1.47 1.44 1.76 1.87 2.03 1.23 1.20 1.202
EBIT Margin -0.25 -0.22 -0.20 -0.19 -0.16 -0.12 -0.08 -0.05 0.00 0.03 0.06 0.07 0.05 0.04 0.03 0.04 0.06 0.058
Asset Turnover 0.20 0.42 0.41 0.57 0.74 0.78 0.64 0.66 0.69 0.72 0.65 0.67 0.69 0.70 0.66 0.67 0.68 0.682
Equity Multiplier 3.21 3.21 1.78 1.78 2.16 2.16 1.83 1.83 1.83 1.83 1.83 1.83 1.83 1.83 1.86 1.86 1.86 1.864
Per Share
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.13 $-0.24 $-0.39 $-0.49 $-0.45 $-0.35 $-0.21 $-0.10 $0.02 $0.11 $0.18 $0.21 $0.19 $0.17 $0.46 $0.43 $0.45 $0.45
Book Value/Share $0.72 $0.72 $2.02 $2.01 $1.99 $1.98 $2.10 $1.95 $1.94 $2.03 $2.36 $2.39 $2.50 $2.59 $2.29 $2.38 $2.31 $2.39
Tangible Book/Share $0.52 $0.51 $1.78 $1.78 $1.76 $1.75 $1.85 $1.72 $1.70 $1.78 $2.18 $2.22 $2.32 $2.40 $2.11 $2.19 $2.13 $2.13
Revenue/Share $0.47 $0.96 $1.49 $2.05 $2.16 $2.26 $2.36 $2.30 $2.38 $2.59 $2.54 $2.66 $2.85 $3.01 $2.98 $3.14 $3.10 $3.46
FCF/Share $-0.04 $-0.06 $-0.13 $-0.15 $-0.10 $-0.09 $0.04 $0.11 $0.13 $0.20 $0.18 $0.26 $0.30 $0.27 $0.22 $0.40 $0.47 $0.63
OCF/Share $-0.03 $-0.03 $-0.09 $-0.10 $-0.05 $-0.04 $0.10 $0.17 $0.20 $0.28 $0.25 $0.33 $0.37 $0.34 $0.29 $0.47 $0.50 $0.64
Cash/Share $1.11 $1.10 $2.08 $2.07 $2.06 $2.05 $2.21 $2.06 $2.04 $2.13 $2.30 $2.33 $2.44 $2.53 $1.81 $1.88 $1.83 $2.03
EBITDA/Share $-0.11 $-0.20 $-0.28 $-0.36 $-0.33 $-0.24 $-0.15 $-0.06 $0.06 $0.13 $0.20 $0.23 $0.20 $0.18 $0.13 $0.16 $0.20 $0.20
Debt/Share $0.31 $0.31 $0.00 $0.00 $0.00 $0.00 $0.06 $0.06 $0.06 $0.06 $0.12 $0.12 $0.12 $0.13 $0.18 $0.19 $0.18 $0.18
Net Debt/Share $-0.80 $-0.79 $-2.08 $-2.07 $-2.06 $-2.05 $-2.14 $-2.00 $-1.98 $-2.07 $-2.18 $-2.22 $-2.31 $-2.40 $-1.63 $-1.69 $-1.64 $-1.64
Per Employee
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Employee Count snapshot only 3,258
Revenue/Employee snapshot only $251923.88
Income/Employee snapshot only $36887.97
EBITDA/Employee snapshot only $16396.56
FCF/Employee snapshot only $38169.12
Assets/Employee snapshot only $363474.22
Market Cap/Employee snapshot only $731314.43
Academic Models
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 2.926
Altman Z-Prime snapshot only 4.786
Piotroski F-Score 2 2 2 2 4 4 6 6 7 7 7 7 8 8 5 6 6 6
Beneish M-Score -2.64 -2.53 -2.56 -2.52 -2.39 -2.36 -2.19 -2.25 -2.32 -2.28 -1.97 -2.15 -2.16 -2.159
Ohlson O-Score snapshot only -8.149
ROIC (Greenblatt) snapshot only 11.63%
Net-Net WC snapshot only $1.07
EVA snapshot only $50755513.59
Credit
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A+
Credit Score 65.42 65.91 63.78 64.54 64.41 61.81 75.57 78.70 78.30 92.13 87.76 92.19 84.26 74.47 77.64 73.36 79.47 79.470
Credit Grade snapshot only 5
Credit Trend snapshot only -4.789
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 68
Sector Credit Rank snapshot only 65

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms